• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG AS VEGA PS TIBIAL PLATEAU CEMENTED T3; KNEE ENDOPROSTHESES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG AS VEGA PS TIBIAL PLATEAU CEMENTED T3; KNEE ENDOPROSTHESES Back to Search Results
Model Number NX055Z
Device Problems Compatibility Problem (2960); Material Integrity Problem (2978); Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problems Pain (1994); Ambulation Difficulties (2544)
Event Type  Injury  
Manufacturer Narrative
As of the date of this report the complaint product was not provided for investigation.Therefore, a thorough investigation is not possible.Batch history review: the device quality and manufacturing history records have been checked for the available lot number and were found to be according to our specifications valid at the time of production.Review of the complaint history revealed that there are 10 similar complaints against the same lot number(s).Conclusion and measures / preventive measures: based upon the investigation results a clear root cause conclusion cannot be drawn.There is no indication for a material-, manufacturing- or design-related failure.In the event that the complaint product will be provided for investigation in the future, an update of this report will be provided unsolicited.Based upon the investigations results there is capa is not necessary.
 
Event Description
It was reported that there was an issue with vega ps tibial plateau.According to the complaint description that as a result of having the product implanted, the patient has experienced pain, difficulty walking, and loosening of the implant.The primary surgery occurred on (b)(6) 2013 and the revision surgery occurred on (b)(6) 2018.Primary surgery: (b)(6) 2013.Revision surgery: (b)(6) 2018.A revision surgery was necessary.All available information has been provided at this time, if additional information becomes available the report will be updated accordingly.The adverse event is filed under aag reference (b)(4).Involved components: nx132 - vega ps gliding surface t3/3+ 14mm - lot 51949663, nn260p - plug f/tibial plateau - lot 51974495, nx013z - as vega ps femoral comp.Cemented f6n l - lot 51927043, nx044 - patella 3-pegs p4 - lot51911583, cement used is unidentified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AS VEGA PS TIBIAL PLATEAU CEMENTED T3
Type of Device
KNEE ENDOPROSTHESES
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
Manufacturer (Section G)
AESCULAP AG
po box 40
tuttlingen, 78501
GM   78501
Manufacturer Contact
christian von der grün
po box 40
tuttlingen, 78501
GM   78501
MDR Report Key11342350
MDR Text Key232337939
Report Number9610612-2020-00261
Device Sequence Number1
Product Code JWH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K101281
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/01/2023
Device Model NumberNX055Z
Device Catalogue NumberNX055Z
Device Lot Number51938561
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/20/2018
Initial Date FDA Received02/18/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/06/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NN260P - 51974495; NX013Z - 51927043; NX044 - 51911583; NX132 - 51949663
Patient Outcome(s) Required Intervention;
-
-